# Project name (project acronym) {#project acronym}

Full information not available yet.

## General summary

**Project number:**  
**Timeline:**  
**Number of waves:**    
**Number of participants:**   
**Age range:**   
**Principal Investigator:**    
**Grant information:**    
**REK code:**  

**Inclusion criteria:** Right handedness, normal (or corrected to normal) vision and hearing, Norwegian as a mother tongue  

**Exclusion criteria:** sleeping disorders, worries about own memory, known central nervous damage or illness (MS, stroke, Parkinson etc.), use of medication against psychological disorders and/or in psychiatric treatment, pregnant and claustrophobic


## Wave 1
### General information
Gangen i prosjektet


**Timeline:**   
**Number of participants:**   
**Age range:**   
**Project managers:**   

### Neuropsychological test battery  


### Computerized tasks


### Questionnaires

_enter list with nettskjema id in parentheses_

### Physiological measures
Finger blood: Vit D, Fatty Acids,   
Saliva (DNA)  
Blood pressure  
Height  
In-Body scan   

### MRI sequence
Siemens Prisma 3T  
MPRAGE T1w  
SPACE T2w 
DTI    
fMRI - Acon1_faceplacemem  
Radiological evaluation: T2 flair    

### fMRI-paradigm


### Actigraphs

### Participant compensation


### PET 
for a sub-sample of participants 50+ years of age  
185 MBq Flutemetamol. Rest 90min before scanning.  

Seqences:  
1. aCT caudal..  
2. PET. One bed 3D. Dynamic, listmode. 4 Frames @ 300s.  

CT parameters  
kV: 120  
mA Range: 50-150 low dose.  

PET:
Iterations: 6  
Subsets: 24  
Filter: VPFX (TOF), SharpIR, 3mm, standard  
Matrix: 256  
Min/bed: 20min  



